Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Xiaoting Wei
Computer Science > Software Engineering
Open-source model platforms have made it easier to publish AI models, but model release alone does not reveal whether models become visible, technically reused, or incorporated into public applications. This study introduces public application transformation as a platform-visible dimension of model impact and examines it through structured Model-Space links on Hugging Face.
A phase II peri-operative study of pembrolizumab plus lenvatinib for mucosal melanoma
|
Abstract Mucosal melanoma is an aggressive malignancy with limited neoadjuvant options. We conducted a single arm, phase II study of neoadjuvant pembrolizumab plus lenvatinib followed by surgery and adjuvant pembrolizumab in resectable mucosal melanoma (NCT04622566) along with exploratory biomarker analysis.
By Lili Mao, Yumei Lai, Hong Zheng, Ming Cui, Lifeng Li, Ziyi Liu, Hongyu Zhou, Linzi Sun, Caili Li, Xiaoting Wei, Xue Bai, Yan Kong, Chuanliang Cui, Zhihong Chi, Xinan Sheng, Bin Lian, Siming Li, Xieqiao Yan, Bixia Tang, Juan Li, Li Zhou Verified, Xuan Wang, Jun Guo, Jie Dai, Lu Si
|
Nature
Verified
Prognostic Impact of Breslow Thickness in Acral Melanoma: A Retrospective Analysis
Abstract Background: Evidence for the prognostic importance of tumor thickness in acral melanoma (AM) patients is limited. Objective: The objective of the study was to determine the prognostic impact of Breslow thickness in AM. Methods: This multicenter study enrolled patients diagnosed with localized AM between January 1, 2000 and December 31, 2017.
Shifts in Structure and Assembly Processes of Root Endophytic Community Caused by Climate Warming and Precipitation Increase in Alpine Grassland
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Clinicopathological features, current status, and progress of primary central nervous system melanoma diagnosis and treatment
The clinical features of primary central nervous melanoma are not typical. Treatment standard is uncertain, and surgical resection is usually the first option. Targeted therapy and immunotherapy might be potential choices for primary CNS melanoma. 1 BACKGROUND The incidence of primary central nervous system (CNS) melanoma is approximately 0.01/100,000 per year, accounting for 1% of all melanomas (Balakrishnan et al., 2015; El Habnouni et al., 2018; Hsieh et al., 2015b; Rosenthal et al., 2003c).
Phase Ib study of anlotinib in combination with anti‐PD‐L1 antibody (TQB2450) in patients with advanced acral melanoma
Supporting Information Filename Description jdv19467-sup-0001-TableS1.docxWord 2007 document , 17.6 KB Supplementary Material
Prognostic value of ulceration varies across Breslow thicknesses and clinical stages in acral melanoma: a retrospective study
ORIGINAL ARTICLE Xiaoting Wei, Xiaoting Wei orcid.org/0000-0002-0612-8465 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Melanoma and Sarcoma, Peking University Cancer Hospital & Institute, Beijing, China These authors contributed equally.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Xiaoting
Contact Xiaoting, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack